Overview
As part of its Global Leaders 2024 series, IAM interviewed attorneys at the pinnacle of the patent law profession including Elizabeth Barnhard. Elizabeth chairs the Pharma/Biotech Practice Group of Leason Ellis. In the interview, Elizabeth spoke to a variety of different topics including mentoring young lawyers, opportunities for lawyers in generative AI, and the current state of the IP transactions space. In addressing the most crucial elements of a world-class IP portfolio in the biotech space, she thoughtfully advised that the biologic therapeutics portfolio should protect the biologic itself a well as functional derivatives, formulations, uses, delivery vehicles, manufacturing processes, diagnostic tests, future improvements, and new uses.
Professionals
Elizabeth Barnhard
Of Counsel
